MedPath

Hacidac

Brand Name: Hacidac

Generic Name: Ranitidine (as Hydrochloride)

Active
Registration Number

DRP-869-02

Dosage Form

Solution For Injection (Im/Iv)

Issuance Date

October 31, 2023

Expiry Date

March 12, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength25 mg/mL
PackagingUSP Type I Glass Ampoule x 2mL in Blister Pack x 5's (Box of 5's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
H2 Receptor Antagonist
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Ranitidine (as Hydrochloride)Active

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform